Product NDC: | 64980-137 |
Proprietary Name: | POTASSIUM CITRATE |
Non Proprietary Name: | POTASSIUM CITRATE |
Active Ingredient(s): | 540 mg/1 & nbsp; POTASSIUM CITRATE |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 64980-137 |
Labeler Name: | Rising Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077440 |
Marketing Category: | ANDA |
Start Marketing Date: | 20060619 |
Package NDC: | 64980-137-01 |
Package Description: | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (64980-137-01) |
NDC Code | 64980-137-01 |
Proprietary Name | POTASSIUM CITRATE |
Package Description | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (64980-137-01) |
Product NDC | 64980-137 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | POTASSIUM CITRATE |
Dosage Form Name | TABLET, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20060619 |
Marketing Category Name | ANDA |
Labeler Name | Rising Pharmaceuticals, Inc. |
Substance Name | POTASSIUM CITRATE |
Strength Number | 540 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Potassium Compounds [Chemical/Ingredient],Potassium Salt [EPC] |